Welcome to the Kids' Library!

Biosimilars and biologics : implementation and monitoring in a healthcare setting

Lucio, Steven, author.
Bethesda, MD : American Society of Health-System Pharmacists, Inc., [2018] 2018

CBO's simulation model of new drug development

Adams, Christopher P., author.
Washington, D.C. : Congressional Budget Office, 2021. 2021

Deficiencies in the 340B drug discount program's database.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2004. 2004

Deficiencies in the oversight of the 340B drug pricing program.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2005. 2005

Experiences of health maintenance organizations with pharmacy benefit management companies.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1997. 1998

FDA warning letters : timeliness and effectiveness.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1999. 1999

FDA warning letters : trends and perspectives.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1999. 1999

How Medicare plans use pharmacies, formularies, & common coverage rules.

[Washington, D.C.] : Department of Health and Human Services, Centers for Medicare & Medicaid Services, 2022. 2022

The impact of high-priced generic drugs on Medicare and Medicaid.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1998. 1998

Intellectual property and public health in the developing world

Azam, Mohammad Monirul, author.
Cambridge : Open Book Publishers, [2016] 2016

Lower Drug Costs Now Act of 2019 : report of the Committee on Energy and Commerce.

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2019]- 2019

Patents and regulatory exclusivities: issues in pharmaceutical innovation and competition

Thomas, John R., 1967- author.
[Washington, D.C.] : Congressional Research Service, [2018?]- 2018